1983
DOI: 10.1016/b978-0-12-695150-9.50011-8
|View full text |Cite
|
Sign up to set email alerts
|

Nonsteroidal Antiinflammatory and Antiarthritic Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
10
0
2

Year Published

1989
1989
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 71 publications
0
10
0
2
Order By: Relevance
“…Since then a large body of experimental evidence has accumulated, but nevertheless the structural requirements of NSAID activity or even reliable quantitative structure-activity relationships (QSAR) are still lacking [4]. A complicating factor is the observation that the locus of competitive binding is not only the catalytic site of cyclooxygenase, but also a supplementary site distinct from, but related to, the catalytic site [5].…”
Section: Introductionmentioning
confidence: 99%
“…Since then a large body of experimental evidence has accumulated, but nevertheless the structural requirements of NSAID activity or even reliable quantitative structure-activity relationships (QSAR) are still lacking [4]. A complicating factor is the observation that the locus of competitive binding is not only the catalytic site of cyclooxygenase, but also a supplementary site distinct from, but related to, the catalytic site [5].…”
Section: Introductionmentioning
confidence: 99%
“…In this context, we decided to investigate two profusely employed NSAIDs named Indomethacin (IMTC) and Diflunisal (DFNS) (For structural formulae of the NSAIDs see Table ), in connection with their possible scavenging action towards photogenerated ROS. Both IMTC, an indolic acid derivative, and DFNS, a salicylic acid derivative, are NSAIDs widely used due to their anti‐inflammatory and analgesic properties . Nevertheless several NSAIDs, especially IMTC, have been reported due to their adverse effects in the human body, particularly related to gastro‐intestinal disorders.…”
Section: Introductionmentioning
confidence: 99%
“…Its derivatives are of wide interest because of their diverse biological activity and clinical applications (Kazimierczuk et al, 2002). Benzimidazole moiety fulfills the minimum structural requirements that are common for anti-inflammatory compounds (Nicholson et al, 1982); (Gund and Jensen, 1983). It had been reported that many compounds containing benzimidazole moiety possess significant analgesic as well as anti-inflammatory activity (Mertens et al, 1987).…”
Section: Introductionmentioning
confidence: 99%